ConductScience.org, home

Paper36087307

Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.

Janelidze S and 16 others. Brain, 2023. Cited by 442 papers, by iCite.

Cite this record

ConductScience Library. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease. Papers, record 36087307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36087307

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
PubMed
Journal
Brain
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
442
iCite
Relative citation ratio, by iCite
52.7
iCite
Revised in PubMed
2023-04-27
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Janelidze SShorenahttps://orcid.org/0000-0002-7729-1702
2Bali DDivya
3Ashton NJNicholas J
4Barthélemy NRNicolas R
5Vanbrabant JJeroen
6Stoops EErik
7Vanmechelen EEugeen
8He YYingxinhttps://orcid.org/0000-0003-2543-4553
9Dolado AOAnna Orduña
10Triana-Baltzer GGallen
11Pontecorvo MJMichael J
12Zetterberg HHenrikhttps://orcid.org/0000-0003-3930-4354
13Kolb HHartmuth
14Vandijck MManu
15Blennow KKaj
16Bateman RJRandall J
17Hansson OOskarhttps://orcid.org/0000-0001-8467-7286

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Cognitive DysfunctionMajor topic
Humans
Female
Aged
Male
tau Proteins
Amyloid beta-Peptides
Brain
Biomarkers

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 NS095773NINDS NIH HHSUnited StatesR01NS095773PubMed and NIHNIH RePORTER
R01 AG068398NIA NIH HHSUnited StatesR01AG068398PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06547099Study to Understand Novel Biomarkers in Researching DementiaBackground

Source ClinicalTrials.gov

Download CSV of trials

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120157306Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.Nat Rev Neurol2010https://conductscience.org/library/papers/20157306PubMed
234353941Phenotyping Alzheimer's disease with blood tests.Science2021https://conductscience.org/library/papers/34353941PubMed
332123386Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.Nat Med2020https://conductscience.org/library/papers/32123386PubMed
434031605Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures.Nat Med2021https://conductscience.org/library/papers/34031605PubMed
521414208pROC: an open-source package for R and S+ to analyze and compare ROC curves.BMC Bioinformatics2011https://conductscience.org/library/papers/21414208PubMed
634859598Blood-based biomarkers for Alzheimer's disease.EMBO Mol Med2022https://conductscience.org/library/papers/34859598PubMed
732183883Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification.Alzheimers Res Ther2020https://conductscience.org/library/papers/32183883PubMed
835195758Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change.Acta Neuropathol2022https://conductscience.org/library/papers/35195758PubMed
926921134Alzheimer's disease.Lancet2016https://conductscience.org/library/papers/26921134PubMed
1025840462Amyloid biomarkers in Alzheimer's disease.Trends Pharmacol Sci2015https://conductscience.org/library/papers/25840462PubMed
1133585983Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.Acta Neuropathol2021https://conductscience.org/library/papers/33585983PubMed
1234083813Biomarkers for neurodegenerative diseases.Nat Med2021https://conductscience.org/library/papers/34083813PubMed
1334542571Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.JAMA Neurol2021https://conductscience.org/library/papers/34542571PubMed
1432725127Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease.J Exp Med2020https://conductscience.org/library/papers/32725127PubMed
1533773595Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment.Alzheimers Res Ther2021https://conductscience.org/library/papers/33773595PubMed
1632722745Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.JAMA2020https://conductscience.org/library/papers/32722745PubMed
1735643092Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.Lancet Neurol2022https://conductscience.org/library/papers/35643092PubMed
1815324362Mild cognitive impairment as a diagnostic entity.J Intern Med2004https://conductscience.org/library/papers/15324362PubMed
1934309632Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.JAMA Neurol2021https://conductscience.org/library/papers/34309632PubMed
2034095436Development and validation of a high-sensitivity assay for measuring p217+tau in plasma.Alzheimers Dement (Amst)2021https://conductscience.org/library/papers/34095436PubMed

See all 35 referencesDownload CSV of references

Cited by346

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 442 citations.

PMIDTitleJournalYearIn PapersSource
42985795Deep Learning for AD Risk Screening and Progression Prediction.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42985795PubMed
42979019Multi-platform comparison of plasma phosphorylated tau assays: analytical and workflow factors drive clinical implementation decisions.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42979019PubMed
42947225Short-interval variability and test-retest reliability of Alzheimer's disease plasma biomarkers in a clinically heterogenous cohort.Alzheimers Res Ther2026https://conductscience.org/library/papers/42947225PubMed
42921107Evaluation of harmonization methods to mitigate assay and cohort effects in plasma p-tau217.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42921107PubMed
42913444Blood-Based Biomarkers as Predictors of All-Cause Dementia: A 13-Year Follow-Up in the Whitehall II Cohort Study.Neurology2026https://conductscience.org/library/papers/42913444PubMed
42909513APOE ε4 accelerates plasma p-tau217 trajectory: a Bayesian joint longitudinal analysis of ADNI.Neurol Sci2026https://conductscience.org/library/papers/42909513PubMed
42905283Clinical performance and decision thresholds of an automated plasma p-tau217 assay for amyloid pathology in a Taiwanese memory clinic.J Neurol2026https://conductscience.org/library/papers/42905283PubMed
42889489Comparison of brain-derived versus conventional pTau biomarkers in CSF and plasma for detecting Alzheimer's disease.Brain Commun2026https://conductscience.org/library/papers/42889489PubMed
42876932Low premorbid IQ effects biomarker-cognition relationships: A pilot study.J Alzheimers Dis Rep2026https://conductscience.org/library/papers/42876932PubMed
42865723Plasma biomarker strategies to reduce diagnostic uncertainty in p-tau217-based assessment of CSF amyloid positivity in secondary-care patients with MCI.Front Aging Neurosci2026https://conductscience.org/library/papers/42865723PubMed
42837647Quantitative Relationship Between Lumipulse G Measures of pTau217 in Plasma and the Temporal Cortex.Neurology2026https://conductscience.org/library/papers/42837647PubMed
42832237Earlier Disclosure of Blood-Based Biomarkers, Diagnostic Certainty, and Clinical Management: A Randomized Clinical Trial.JAMA Neurol2026https://conductscience.org/library/papers/42832237PubMed
42821845Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers.Neurology2026https://conductscience.org/library/papers/42821845PubMed
42799937Motor speech markers of Alzheimer's risk.Geroscience2026https://conductscience.org/library/papers/42799937PubMed
42780170Epitope placement tunes CSF tau biomarkers: Comparison of P-tau217 and BD-tau designs.Mol Neurodegener Adv2026https://conductscience.org/library/papers/42780170PubMed
42745326Enhancing Alzheimer's disease diagnosis in primary care through targeted screening of people at risk of developing dementia - study design and feasibility assessment of the PREDEM primary care study.Alzheimers Res Ther2026https://conductscience.org/library/papers/42745326PubMed
42733037Cerebral oxygen extraction fraction as a physiological biomarker in vascular cognitive impairment: A study in older adults enriched for small vessel diseases.Alzheimers Dement2026https://conductscience.org/library/papers/42733037PubMed
42719535Elecsys pT181p immunoassay: Clinical performance for ruling out amyloid pathology.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42719535PubMed
42698737Translating blood-based biomarkers into Alzheimer's disease clinical practice: screening, diagnosis, and longitudinal monitoring.Front Aging Neurosci2026https://conductscience.org/library/papers/42698737PubMed
42694243Blood-based biomarkers of Alzheimer's disease and neurodegeneration in an indigenous African cohort using both Simoa and NULISA platforms.NPJ Dement2026https://conductscience.org/library/papers/42694243PubMed

See all 346 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOE348PubTator's text mininghttps://conductscience.org/library/genes/348NCBI Gene
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36087307

GET https://conductscience.org/api/papers/v1/36087307/references?page=2